Revised Medical Criteria for Evaluating Cancer (Malignant Neoplastic Diseases)Carolyn W. Colvin
C. Blood pyruvate in malignant neoplastic disorders. Clin. Chem. 12, 158–164 (1966). CAS PubMed Google Scholar Jobard, E. et al. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Lett. 343, 33–41 (2014). CAS PubMed Google...
This Mendelian randomization study evaluates the causal relevance of telomere length for risk of cancer and non-neoplastic diseases.
Interestingly, there is also growing evidence that the canonical theory of renegade clonal expansion in carcinogenesis [116] may not be the only manner in which malignant development proceeds. The theory of clonal expansion posits that clones of cells harboring oncogenic drivers will be selected during...
Ch 19. Urinary System Diseases Ch 20. Clinical Tests of the Urinary... Ch 21. Disorders of the Reproductive... Ch 22. Studying for Biology 106Thyroid Cancer: An Example of Malignant Neoplasia Related Study Materials Browse by Courses Earth Science: Middle School Health 101: Principles of Heal...
The updated guidelines introduce new insights into the management of these diseases. Melanoma (MM), the third most common skin cancer, a malignant melanocytic tumor, which is classified into four major histological subtypes, continues to have the potential to be a lethal disease. The mortality–...
ID13 was characterized predominantly by deletions of thymine at thymine–thymine dinucleotides and exhibited large numbers of mutations in malignant melanomas of the skin (Figs. 2, 3). The numbers of ID13 mutations correlated with the numbers of SBS7a, SBS7b and DBS1 mutations, which we have...
The basic questions about cancer must be answered to demystify this scary disease and solve the “Oncogenic Paradox” described by the Nobel Prize laureate Albert Szent-Gyorgyi [1]: “The malignant transformation of tissues … is a very specific process which must involve very specific changes...
Both GPR4 and TDAG8 (GPR65) have been shown to be overexpressed in many cancers and can cause malignant transformation of cells in vitro (107). GPR132 (also known as G2A) was previously shown to have tumor suppressor properties, as it prevents oncogenic transformations of pre-B cells by ...
The distinction of liver lesions is critical for the accurate diagnosis and treatment of liver cancer. Here, the authors develop LiLNet, a deep learning-based system to identify focal liver lesions as well as benign and malignant liver tumours from CT images with high accuracy across multiple pat...